One page, thousands of outlets. See who else covered it.
Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
European shares inched up on Monday, led by basic resources stocks as gold prices advanced on a weaker dollar and softer US economic data, while easing expectations of a Federal Reserve rate hike…
Jain Global is expanding its Asian presence with new hires and additional office space in Hong Kong as Bobby Jain’s multi-strategy hedge fund prepares to transition away from external investors and…
This week brings earnings from Target, Walmart and others
JOHANNESBURG: The South African rand firmed against the US dollar in early trade on Monday as investors looked ahead to inflation data later this week for clues on the health of Africa’s largest…
Trotz geopolitischer Spannungen haben die Asienbörsen zugelegt. Anleger in Japan wetten indes auf eine Zinserhöhung. Die japanischen Anleiherenditen notieren auf dem höchsten Wert seit 1996.